|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,810 KRW | +12.85% |
|
-22.16% | -57.23% |
Curable. Inc. (XKON:A086460) agreed to acquire 8.5% stake in Pharma Biotech Korea Co., Ltd from Pharma Biotech Korea for KRW 8.5 billion on January 19, 2023. KRW 5.1 billion of cash and offset loan of Pharma Biotech Korea KRW 3.4 million.
The transaction is expected to complete on January 20, 2023.
| 1st Jan change | Capi. | |
|---|---|---|
| -57.23% | 60.22L | |
| -39.33% | 840.53Cr | |
| +11.77% | 381.67Cr | |
| -0.18% | 232.82Cr | |
| -19.52% | 202.25Cr | |
| -21.74% | 166.73Cr | |
| +30.00% | 114.37Cr | |
| +27.83% | 76Cr | |
| -9.39% | 70Cr | |
| -19.69% | 57Cr |
CURABLE. INC. 
